Eosinophilic esophagitis: current perspectives from diagnosis to management

Fouad J. Moawad, Edaire Cheng, Alain Schoepfer, Sahar Al-Haddad, Andrew M. Bellizzi, Heather Dawson, Hala El-Zimaity, Maha Guindi, Roberto Penagini, Ekaterina Safrooneva, Mirna Chehade

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Eosinophilic esophagitis (EoE) is a chronic antigen-mediated immune disease of the esophagus characterized by symptoms related to esophageal dysfunction, as well as significant esophageal eosinophilia. Although dense eosinophilia is the hallmark of EoE, other characteristic histologic features have been described that may help distinguish EoE from other competing diagnoses, although none are specific to EoE. One or more foods and, at times, environmental allergens trigger EoE. Left untreated, esophageal inflammation in EoE may lead to esophageal remodeling and stricture formation. Symptoms in EoE vary with age, as they relate to the progression of the disease from an inflammatory to a fibrostenotic phenotype over time. There are currently no U.S. Food and Drug Administration–approved therapies for EoE. Current options include various dietary-restriction therapies, topical corticosteroids, and esophageal dilations. Several emerging therapies aiming at restoring the esophageal barrier function or targeting various inflammatory cells or their mediators are under investigation.

Original languageEnglish (US)
Pages (from-to)204-217
Number of pages14
JournalAnnals of the New York Academy of Sciences
Volume1380
Issue number1
DOIs
StatePublished - Sep 1 2016

Fingerprint

Eosinophilic Esophagitis
Drug therapy
Allergens
Adrenal Cortex Hormones
Antigens
Eosinophilia
Food
Esophageal Stenosis
Therapy
Immune System Diseases
Esophagus
Disease Progression
Dilatation
Inflammation
Phenotype
Drug Therapy

Keywords

  • allergy
  • corticosteroids
  • dietary treatment
  • dilation
  • dysphagia
  • eosinophilia
  • eosinophilic esophagitis
  • esophagitis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Moawad, F. J., Cheng, E., Schoepfer, A., Al-Haddad, S., Bellizzi, A. M., Dawson, H., ... Chehade, M. (2016). Eosinophilic esophagitis: current perspectives from diagnosis to management. Annals of the New York Academy of Sciences, 1380(1), 204-217. https://doi.org/10.1111/nyas.13164

Eosinophilic esophagitis : current perspectives from diagnosis to management. / Moawad, Fouad J.; Cheng, Edaire; Schoepfer, Alain; Al-Haddad, Sahar; Bellizzi, Andrew M.; Dawson, Heather; El-Zimaity, Hala; Guindi, Maha; Penagini, Roberto; Safrooneva, Ekaterina; Chehade, Mirna.

In: Annals of the New York Academy of Sciences, Vol. 1380, No. 1, 01.09.2016, p. 204-217.

Research output: Contribution to journalArticle

Moawad, FJ, Cheng, E, Schoepfer, A, Al-Haddad, S, Bellizzi, AM, Dawson, H, El-Zimaity, H, Guindi, M, Penagini, R, Safrooneva, E & Chehade, M 2016, 'Eosinophilic esophagitis: current perspectives from diagnosis to management', Annals of the New York Academy of Sciences, vol. 1380, no. 1, pp. 204-217. https://doi.org/10.1111/nyas.13164
Moawad, Fouad J. ; Cheng, Edaire ; Schoepfer, Alain ; Al-Haddad, Sahar ; Bellizzi, Andrew M. ; Dawson, Heather ; El-Zimaity, Hala ; Guindi, Maha ; Penagini, Roberto ; Safrooneva, Ekaterina ; Chehade, Mirna. / Eosinophilic esophagitis : current perspectives from diagnosis to management. In: Annals of the New York Academy of Sciences. 2016 ; Vol. 1380, No. 1. pp. 204-217.
@article{02782e2140a7419c81e65af60e2f8674,
title = "Eosinophilic esophagitis: current perspectives from diagnosis to management",
abstract = "Eosinophilic esophagitis (EoE) is a chronic antigen-mediated immune disease of the esophagus characterized by symptoms related to esophageal dysfunction, as well as significant esophageal eosinophilia. Although dense eosinophilia is the hallmark of EoE, other characteristic histologic features have been described that may help distinguish EoE from other competing diagnoses, although none are specific to EoE. One or more foods and, at times, environmental allergens trigger EoE. Left untreated, esophageal inflammation in EoE may lead to esophageal remodeling and stricture formation. Symptoms in EoE vary with age, as they relate to the progression of the disease from an inflammatory to a fibrostenotic phenotype over time. There are currently no U.S. Food and Drug Administration–approved therapies for EoE. Current options include various dietary-restriction therapies, topical corticosteroids, and esophageal dilations. Several emerging therapies aiming at restoring the esophageal barrier function or targeting various inflammatory cells or their mediators are under investigation.",
keywords = "allergy, corticosteroids, dietary treatment, dilation, dysphagia, eosinophilia, eosinophilic esophagitis, esophagitis",
author = "Moawad, {Fouad J.} and Edaire Cheng and Alain Schoepfer and Sahar Al-Haddad and Bellizzi, {Andrew M.} and Heather Dawson and Hala El-Zimaity and Maha Guindi and Roberto Penagini and Ekaterina Safrooneva and Mirna Chehade",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/nyas.13164",
language = "English (US)",
volume = "1380",
pages = "204--217",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Eosinophilic esophagitis

T2 - current perspectives from diagnosis to management

AU - Moawad, Fouad J.

AU - Cheng, Edaire

AU - Schoepfer, Alain

AU - Al-Haddad, Sahar

AU - Bellizzi, Andrew M.

AU - Dawson, Heather

AU - El-Zimaity, Hala

AU - Guindi, Maha

AU - Penagini, Roberto

AU - Safrooneva, Ekaterina

AU - Chehade, Mirna

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Eosinophilic esophagitis (EoE) is a chronic antigen-mediated immune disease of the esophagus characterized by symptoms related to esophageal dysfunction, as well as significant esophageal eosinophilia. Although dense eosinophilia is the hallmark of EoE, other characteristic histologic features have been described that may help distinguish EoE from other competing diagnoses, although none are specific to EoE. One or more foods and, at times, environmental allergens trigger EoE. Left untreated, esophageal inflammation in EoE may lead to esophageal remodeling and stricture formation. Symptoms in EoE vary with age, as they relate to the progression of the disease from an inflammatory to a fibrostenotic phenotype over time. There are currently no U.S. Food and Drug Administration–approved therapies for EoE. Current options include various dietary-restriction therapies, topical corticosteroids, and esophageal dilations. Several emerging therapies aiming at restoring the esophageal barrier function or targeting various inflammatory cells or their mediators are under investigation.

AB - Eosinophilic esophagitis (EoE) is a chronic antigen-mediated immune disease of the esophagus characterized by symptoms related to esophageal dysfunction, as well as significant esophageal eosinophilia. Although dense eosinophilia is the hallmark of EoE, other characteristic histologic features have been described that may help distinguish EoE from other competing diagnoses, although none are specific to EoE. One or more foods and, at times, environmental allergens trigger EoE. Left untreated, esophageal inflammation in EoE may lead to esophageal remodeling and stricture formation. Symptoms in EoE vary with age, as they relate to the progression of the disease from an inflammatory to a fibrostenotic phenotype over time. There are currently no U.S. Food and Drug Administration–approved therapies for EoE. Current options include various dietary-restriction therapies, topical corticosteroids, and esophageal dilations. Several emerging therapies aiming at restoring the esophageal barrier function or targeting various inflammatory cells or their mediators are under investigation.

KW - allergy

KW - corticosteroids

KW - dietary treatment

KW - dilation

KW - dysphagia

KW - eosinophilia

KW - eosinophilic esophagitis

KW - esophagitis

UR - http://www.scopus.com/inward/record.url?scp=84979747860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979747860&partnerID=8YFLogxK

U2 - 10.1111/nyas.13164

DO - 10.1111/nyas.13164

M3 - Article

C2 - 27467185

AN - SCOPUS:84979747860

VL - 1380

SP - 204

EP - 217

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -